Organization | Pflugerville Dermatology Clinical Research

Pflugerville Dermatology Clinical Research Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial

2014

NCT02249104

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 4 Trials (5)

adapalene (differin) (1 trial)

benzoyl peroxide (clearasil) (1 trial)

palmityl alcohol (1 trial)

propylene glycol (1 trial)

sodium monododecyl sulfate (1 trial)

Drugs in Phase 1 Trials (1)

ingenol mebutate (picato) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acne Vulgaris (Phase 4)

Keratosis (Phase 1)

Keratosis, Actinic (Phase 1)

Overview

Highest Phase: Phase 4
# of Trials: 2
# of Trial APIs: 6